Ramipril Capsules — Class III drug recall D-0118-2017
Ongoing recall by Actavis Laboratories, FL, Inc., reported 2016-11-09, distributed nationwide. Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/1
| Recall number | D-0118-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Actavis Laboratories, FL, Inc., Davie, FL, United States |
| Recall initiated | 2016-08-30 |
| Classified | 2016-11-01 |
| Reported by FDA | 2016-11-09 |
| Distributed | Nationwide (US) |
| Quantity | 15,984 bottles |
| Reason classes | labeling |
| NDC | 16252-0570-30 |
| Lot numbers | 1136091A |
Product
Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.
Reason for recall
Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0118-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.